NCT06218303 2026-03-12Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In SituUniversity of PittsburghPhase 1 Recruiting50 enrolled
NCT04144023 2026-03-05A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In SituMayo ClinicPhase 1 Recruiting43 enrolled